Results 11 to 20 of about 781,057 (345)

Screening for diabetic retinopathy: new perspectives and challenges

open access: yesLancet Diabetes and Endocrinology,the, 2020
Stela Vujosevic   +2 more
exaly   +2 more sources

Diabetic retinopathy: Looking forward to 2030

open access: yesFrontiers in Endocrinology, 2023
Diabetic retinopathy (DR) is the major ocular complication of diabetes mellitus, and is a problem with significant global health impact. Major advances in diagnostics, technology and treatment have already revolutionized how we manage DR in the early ...
Tien-En Tan, T. Y. Wong
semanticscholar   +1 more source

DIFFERENCES OF APOLIPOPROTEIN A1 AND APOLIPOPROTEIN B LEVELS IN TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS WITH DIABETIC RETINOPATHY AND WITHOUT DIABETIC RETINOPATHY

open access: yesIJRETINA (International Journal of Retina), 2021
Introduction Apolipoprotein A1 are antiatherogenic in blood serum and have an anti-inflammatory while Apolipoprotein B describes a protein structure that is potentially atherogenic..
shabrina hanifah   +4 more
doaj   +1 more source

Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation

open access: yesThe EPMA Journal, 2023
Proliferative diabetic retinopathy (PDR) the sequel of diabetic retinopathy (DR), a frequent complication of diabetes mellitus (DM), is the leading cause of blindness in the working-age population.
Martina Kropp   +12 more
semanticscholar   +1 more source

Characteristics Associated with Early Worsening of Retinopathy in Patients with Type 2 Diabetes Diagnosed with Retinopathy at Their First Visit: A Retrospective Observational Study

open access: yesJournal of Diabetes Research, 2021
Aims/Introduction. To investigate whether the occurrence of early worsening of diabetic retinopathy in patients with type 2 diabetes diagnosed with simple or preproliferative diabetic retinopathy at their first visit differed according to HbA1c reduction
Sayaka Wakabayashi Sugawa   +6 more
doaj   +1 more source

Prevalence of Diabetic Retinopathy in the US in 2021.

open access: yesJAMA ophthalmology, 2023
Importance Diabetic retinopathy (DR) is a common microvascular complication of diabetes and a leading cause of blindness among working-age adults in the US.
E. Lundeen   +6 more
semanticscholar   +1 more source

Efficacy of intravitreal AFlibercept injection For Improvement of retinal Nonperfusion In diabeTic retinopathY (AFFINITY study)

open access: yesBMJ Open Diabetes Research & Care, 2020
Introduction To evaluate the effects of intravitreal aflibercept injection on retinal nonperfusion in patients with diabetic retinopathy (DR) using ultrawide field (UWF) fluorescein angiography (FA).Research design and methods Thirty-eight eyes of 38 ...
Young Hee Yoon   +2 more
doaj   +1 more source

A Hybrid Convolutional Neural Network Model for Automatic Diabetic Retinopathy Classification From Fundus Images

open access: yesIEEE Journal of Translational Engineering in Health and Medicine, 2023
Objective: Diabetic Retinopathy (DR) is a retinal disease that can cause damage to blood vessels in the eye, that is the major cause of impaired vision or blindness, if not treated early.
Ghulam Ali   +4 more
semanticscholar   +1 more source

Retinal Cell Damage in Diabetic Retinopathy

open access: yesCells, 2023
Diabetic retinopathy (DR), the most common microvascular complication that occurs in diabetes mellitus (DM), is the leading cause of vision loss in working-age adults. The prevalence of diabetic retinopathy is approximately 30% of the diabetic population
Jing Zhou, Bo Chen
semanticscholar   +1 more source

Research progress on the pathogenesis of diabetic retinopathy

open access: yesBMC Ophthalmology, 2023
Diabetic retinopathy is one of the most common and serious microvascular complications of diabetes mellitus. There are many factors leading to diabetic retinopathy, and its pathogenesis is still unclear.
Hongbo Li   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy